Epoch Investment Partners’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-4,379
| Closed | -$242K | – | 228 |
|
|
2026
Q1 | $242K | Buy |
+4,379
| New | +$237K | ﹤0.01% | 230 |
|
|
2021
Q3 | – | Sell |
-4,278
| Closed | -$213K | – | 355 |
|
|
2021
Q2 | $213K | Buy |
+4,278
| New | +$206K | ﹤0.01% | 339 |
|
|
2021
Q1 | – | Sell |
-4,890
| Closed | -$225K | – | 327 |
|
|
2020
Q4 | $225K | Sell |
4,890
-233
| -5% | -$10.7K | ﹤0.01% | 323 |
|
|
2020
Q3 | $241K | Sell |
5,123
-391
| -7% | -$19.6K | ﹤0.01% | 294 |
|
|
2020
Q2 | $281K | Sell |
5,514
-604
| -10% | -$31K | ﹤0.01% | 280 |
|
|
2020
Q1 | $290K | Buy |
6,118
+574
| +10% | +$30.6K | ﹤0.01% | 263 |
|
|
2019
Q4 | $326K | Sell |
5,544
-1,046
| -16% | -$58.2K | ﹤0.01% | 284 |
|
|
2019
Q3 | $352K | Sell |
6,590
-2,729
| -29% | -$140K | ﹤0.01% | 267 |
|
|
2019
Q2 | $466K | Sell |
9,319
-2,688
| -22% | -$135K | ﹤0.01% | 271 |
|
|
2019
Q1 | $627K | Buy |
12,007
+876
| +8% | +$43.8K | ﹤0.01% | 287 |
|
|
2018
Q4 | $532K | Sell |
11,131
-4,835
| -30% | -$238K | ﹤0.01% | 283 |
|
|
2018
Q3 | $802K | Sell |
15,966
-2,145
| -12% | -$109K | ﹤0.01% | 287 |
|
|
2018
Q2 | $913 | Sell |
18,111
-4,212
| -19% | -$212K | ﹤0.01% | 292 |
|
|
2018
Q1 | $1.09M | Buy |
22,323
+1,805
| +9% | +$84.1K | ﹤0.01% | 283 |
|
|
2017
Q4 | $910K | Buy |
20,518
+1,109
| +6% | +$51.2K | ﹤0.01% | 284 |
|
|
2017
Q3 | $985K | Buy |
19,409
+4,155
| +27% | +$211K | ﹤0.01% | 284 |
|
|
2017
Q2 | $822K | Sell |
15,254
-828
| -5% | -$44.1K | ﹤0.01% | 283 |
|
|
2017
Q1 | $848K | Sell |
16,082
-904
| -5% | -$45.9K | ﹤0.01% | 294 |
|
|
2016
Q4 | $818K | Sell |
16,986
-7,263
| -30% | -$359K | ﹤0.01% | 272 |
|
|
2016
Q3 | $1.31M | Sell |
24,249
-77
| -0.3% | -$4.22K | ﹤0.01% | 268 |
|
|
2016
Q2 | $1.32M | Buy |
24,326
+2,164
| +10% | +$114K | ﹤0.01% | 252 |
|
|
2016
Q1 | $1.12M | Buy |
22,162
+357
| +2% | +$17.8K | ﹤0.01% | 248 |
|
|
2015
Q4 | $1.1M | Sell |
21,805
-1,629
| -7% | -$83K | ﹤0.01% | 250 |
|
|
2015
Q3 | $1.13M | Sell |
23,434
-734
| -3% | -$38.2K | ﹤0.01% | 219 |
|
|
2015
Q2 | $1.26M | Buy |
24,168
+430
| +2% | +$24.2K | ﹤0.01% | 222 |
|
|
2015
Q1 | $1.37M | Sell |
23,738
-61,831
| -72% | -$3.54M | 0.01% | 218 |
|
|
2014
Q4 | $4.57M | Sell |
85,569
-6,043
| -7% | -$338K | 0.02% | 206 |
|
|
2014
Q3 | $5.26M | Buy |
91,612
+5,054
| +6% | +$310K | 0.02% | 213 |
|
|
2014
Q2 | $5.79M | Buy |
86,558
+4,146
| +5% | +$281K | 0.02% | 215 |
|
|
2014
Q1 | $5.5M | Buy |
+82,412
| New | +$5.57M | 0.02% | 219 |
|
|
2013
Q4 | – | Sell |
-55,833
| Closed | -$3.5M | – | 265 |
|
|
2013
Q3 | $3.5M | Buy |
55,833
+3,228
| +6% | +$208K | 0.02% | 232 |
|
|
2013
Q2 | $3.29M | Buy |
+52,605
| New | +$3.34M | 0.02% | 220 |
|
Other funds holding GSK
JEST
Epoch Investment Partners's GSK Position: Q2 2026 in Review
Epoch Investment Partners sold out of GSK (GSK) in Q2 2026, closing a stake of 4,379 shares — an estimated $242K sold.
Epoch Investment Partners first reported a position in GSK in Q2 2013 and held it in 32 quarters. The position peaked at $5.79M in Q2 2014. 1,037 funds tracked by Wall St. Rank hold GSK as of Q2 2026.
- Epoch Investment Partners reported no remaining GSK position as of Q2 2026 after selling out during the quarter.
- Epoch Investment Partners sold 4,379 GSK shares in Q2 2026, an estimated $242K.
- Epoch Investment Partners first reported a position in GSK in Q2 2013 and held it in 32 quarters.
- Epoch Investment Partners's GSK position peaked at $5.79M in Q2 2014.
- 1,037 funds tracked by Wall St. Rank held GSK as of Q2 2026.
Based on Epoch Investment Partners's 13F filing for Q2 2026, filed 13 Aug 2026.